Variant report
Variant | nsv976373 |
---|---|
Chromosome Location | chr14:105077690-105078597 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536998748 | chr14:105077693-105077694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185348314 | chr14:105077700-105077701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs578192060 | chr14:105077711-105077712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs60899596 | chr14:105077726-105077727 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs10136712 | chr14:105077727-105077728 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs553019431 | chr14:105077735-105077736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572989465 | chr14:105077856-105077857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139844062 | chr14:105077870-105077871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375860185 | chr14:105077872-105077873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77355633 | chr14:105077910-105077911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188893000 | chr14:105077934-105077935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560852713 | chr14:105077957-105077958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76630787 | chr14:105078032-105078033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77526295 | chr14:105078043-105078044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559838781 | chr14:105078053-105078054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181379767 | chr14:105078094-105078095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545178648 | chr14:105078097-105078098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs58491824 | chr14:105078115-105078116 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs10136937 | chr14:105078153-105078154 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs143168234 | chr14:105078209-105078210 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550693060 | chr14:105078210-105078211 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4340263 | chr14:105078251-105078252 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs536294660 | chr14:105078265-105078266 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553222919 | chr14:105078266-105078267 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573063465 | chr14:105078267-105078268 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56013109 | chr14:105078279-105078280 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558800677 | chr14:105078296-105078297 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs58151147 | chr14:105078299-105078300 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs145459142 | chr14:105078337-105078338 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561014150 | chr14:105078372-105078373 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574366896 | chr14:105078377-105078378 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539859376 | chr14:105078380-105078381 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149228913 | chr14:105078398-105078399 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528802440 | chr14:105078419-105078420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551914217 | chr14:105078460-105078461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529277317 | chr14:105078469-105078470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565120005 | chr14:105078506-105078507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531035358 | chr14:105078529-105078530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs36009192 | chr14:105078561-105078562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Breast cancer | 20932292 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:105077400-105078400 | Enhancers | Fetal Brain Male | brain |
2 | chr14:105077600-105078000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr14:105078000-105078400 | Enhancers | Brain Germinal Matrix | brain |
4 | chr14:105078200-105078400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr14:105078200-105078400 | Enhancers | Fetal Brain Female | brain |
6 | chr14:105078400-105083200 | Weak transcription | Fetal Brain Male | brain |